Cancer Treatment Centers Of America Is Fighting Cancer In A Totally New Way

Prostate cancer affects one in five African-American men. That is significantly greater than the overall rate of one of every seven men. To reduce the risk associated with prostate cancer, routine screenings and proper education are important. In hopes of making prostate screenings more accessible, three organizations are working together to provide free and low-cost screenings to qualified men.

Earlier this year, Cancer Treatment Centers of America teamed up with the National Football League Alumni Association to raise awareness prostate cancer. From September 1 to October 15, 2,000 men aged 40 and over received free Prostate Specific Antigen screenings through LabCorp. After the first 2,000 slots were filled, the trio continued to offer screenings at a discounted rate of $25, making the screenings accessible to virtually everyone.

The American Cancer Society estimates there will be more than 160,000 me diagnosed with prostate cancer in 2017. Men who are considered high-risk are encouraged to begin screening early, to reduce effects of the condition, and begin treatment as quickly as possible.

Cancer Treatment Centers of America is a national network of five private hospitals, founded in 1988. When founder Richard J Stephenson lost his mother to cancer, he was motivated to make a change in the available treatment options. Cancer Treatment Centers of America uses a combination of traditional options like chemotherapy and radiation along with several integrative therapies to deliver the best treatment options to their patients. Their commitment to patient care is evidenced in their strong patient satisfaction surveys and their consistency as top performers on Key Quality Measures and the Magnet Award. The network has also earned a Five Star rating by the U.S. Centers for Medicare and Medicaid Sevices.

Since opening their first hospital in Zion, Illinois, Cancer Treatment Centers of America has completely committed themselves to patient care and revolutionizing the world of cancer treatment.

Leave a Reply

Your email address will not be published. Required fields are marked *